SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

McClure Matthew W. – ‘4’ for 2/27/24 re: Aligos Therapeutics, Inc.

On:  Wednesday, 2/28/24, at 5:33pm ET   ·   For:  2/27/24   ·   As:  Officer   ·   Accession #:  1610717-24-100   ·   File #:  1-39617

Previous ‘4’:  ‘4’ on 9/12/23 for 9/8/23   ·   Next & Latest:  ‘4’ on 3/4/24 for 3/1/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  McClure Matthew W.                4          Officer     1:13K  Aligos Therapeutics, Inc.         Latham & Watk… Agent)/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     13K 
                Securities by an Insider -- form4.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  2/27/24
Issuer:
Issuer CIK:  1799448
Issuer Name:  Aligos Therapeutics, Inc.
Issuer Trading Symbol:  ALGS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1927121
Owner Name:  McClure Matthew W.
Reporting Owner Address:
Owner Street 1:  C/O ALIGOS THERAPEUTICS, INC.
Owner Street 2:  1 CORPORATE DRIVE, 2ND FLOOR
Owner City:  SOUTH SAN FRANCISCO
Owner State:  CA
Owner ZIP Code:  94080
Owner State Description:
Reporting Owner Relationship:
Is Officer?  Yes
Officer Title:  Chief Medical Officer
Aff 10b5 One?  No
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  16.18
Transaction Date:
Value:  2/27/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  255,626
Transaction Price Per Share:
Value:  0
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  1/1/21
Expiration Date:
Value:  12/1/30
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  255,626
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  3.06
Transaction Date:
Value:  2/27/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  92,000
Transaction Price Per Share:
Value:  0
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  3/4/22
Expiration Date:
Value:  2/4/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  92,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  3.06
Transaction Date:
Value:  2/27/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  23,000
Transaction Price Per Share:
Value:  0
Footnote ID:  F3
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  2/4/25
Expiration Date:
Value:  2/4/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  23,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  0.96
Transaction Date:
Value:  2/28/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  75,183
Transaction Price Per Share:
Value:  0
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F4
Expiration Date:
Value:  12/1/30
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  75,183
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  75,183
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  0.96
Transaction Date:
Value:  2/28/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  65,713
Transaction Price Per Share:
Value:  0
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F5
Expiration Date:
Value:  2/4/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  65,713
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  65,713
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  0.96
Transaction Date:
Value:  2/28/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  16,428
Transaction Price Per Share:
Value:  0
Footnote ID:  F3
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F4
Expiration Date:
Value:  2/4/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  16,428
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  16,428
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1:  On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 255,626 of the issuer's shares granted to the reporting person on December 1, 2020. In exchange, on February 28, 2024, the reporting person received a replacement option, for 75,183 shares, having an exercise price of $0.96 per share.
Footnote - F2:  On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 92,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 65,713 shares, having an exercise price of $0.96 per share.
Footnote - F3:  On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 23,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 16,428 shares, having an exercise price of $0.96 per share.
Footnote - F4:  The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
Footnote - F5:  The shares subject to the option will vest and become exercisable as to 75% of the total number of shares subject to the option on the one year anniversary of the date of the grant and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued service with the issuer on each such vesting date.
Owner Signature:
Signature Name:  /s/ Lesley Ann Calhoun, as attorney-in fact for Matthew W. McClure
Signature Date:  2/28/24


↑Top
Filing Submission 0001610717-24-000100   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 1:03:35.1pm ET